Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 03 Jul 2024 19:23:19 +0200Wed, 22 May 2024 11:00:00 +0200Human medicines European public assessment report (EPAR): Stayveer, bosentan monohydrate, Date of authorisation: 24/06/2013, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/stayveerHuman medicines European public assessment report (EPAR): Stayveer, bosentan monohydrate, Date of authorisation: 24/06/2013, Revision: 17, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/stayveerWed, 22 May 2024 11:00:00 +0200Human medicineStayveer : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500145169_en.pdfStayveer : EPAR - All Authorised presentationshttps://www.ema.europa.eu/system/files/documents/all-authorised-presentations/wc500145169_en.pdfWed, 12 Oct 2016 18:30:00 +0200Human medicine